Magazine
- Back
- Latest Issue: 07 Aug 2025
- Archives
  
  31 Jul 2025
  
  24 Jul 2025
  
  17 Jul 2025
  
  10 Jul 2025
  View all
- More Reading
Tools
- Back
- Market Data
  - Back
  - Share Prices
  - Indices
  - Funds
  - Forex
  - IPOs
  - Market Diary
- Market Tools
  - Back
  - Portfolio
  - Stockwatch
  - Market Scan
  - Charts
  - Alerts
- Director Deals
  - Back
  - Director Deals
  - Latest Deals
  - Analysis
  - Search
  - Alerts
News
- Back
- Shares News
  Shares journalists news and views on today's breaking stories.
- Market & Company News
  A comprehensive daily news service of over 300 market and company stories from Alliance News and the RNS.
Awards
- Back
- Investment Awards
  
  The AJ Bell Investment Awards is your chance to vote for your pick of active and passive funds.
Events
- Back
- Upcoming Events
  
  Shares Spotlight Event
  
  Farmers and Fletchers in the City, EC1A 7LD
  
  Tuesday 2 September 2025
  
  This event will feature the following companies: Aberdeen Asian Income Fund, JPMorgan Claverhouse Investment Trust, Schroder Oriental Income Fund and Strategic Equity Capital
  
  Previous Events
- Previous Events
Videos
Podcasts
Contact us and help Subscribe

Shares News

Late market roundup: FTSE 100 nears highs as US rate cut bets rise

London stocks edged higher on Wednesday as building expectations for US interest rate cuts buoyed investor confidence, helping the FTSE 100 head towards record levels. Joshua Mahoney, analyst at Rostro, said markets are confident that the Fed will slash rates in the months to come. 'Market pricing for a rate cut at each of the remaining three meetings of 2025 have tipped...

13 August 2025, 16:04

Shares up and pound nears $1.36 on Fed rate-cut hope

The FTSE 100's advance eased going into Wednesday afternoon, as a weaker Brent price hit oil majors, but the mood in equity markets remained optimistic on a growing expectation that the Federal Reserve will cut rates next month. The FTSE 100 index inched up 4.87 points, 0.1%, at 9,152.68. The FTSE 250 added 46.46 points, 0.2%, at 21,889.15, and the AIM All-Share rose 0.55...

13 August 2025, 11:09

Evoke shares gain after strong first half

First-half revenue up 3% EBITDA growth of 44% Full-year target reiterated William Hill and 888 owner Evoke (EVOK) pleased markets after reporting a fourth consecutive quarter of revenue growth and a big jump in profitability, sending the shares up 4% to 65p. The shares have gained 7% so far in 2025, lagging the 10% advance in the FTSE All-Share index. > More detailed chart...

13 August 2025, 10:34

Hill & Smith shares gain on share buyback and half-year profit rise

1H earnings per share up 10% £100 million share buyback Stock hits new high for 2025 Engineering group Hill & Smith (HILS) impressed investors this morning with a 4% rise in underlying revenue and an 11% rise in underlying operating profit (on a constant currency basis) for the six months ending 30 June. The shares gained 264p or more than 13% to £22.32 in early trading...

13 August 2025, 08:51

Beazley shares hit three-month low on outlook cut

Premium growth forecast lowered Through-the-cycle profit the priority Shares were trading at life-high Investors are usually supportive of Beazley's (BEZ) cautious approach to delivering growth through the insurance cycle, which explains why the shares have been trading at record highs, but on this occasion they seem to have taken exception to the firm's decision to rein in...

13 August 2025, 08:49

Shares up as Fed cut bets build after US inflation data

Stocks in Europe were higher on Wednesday morning, amid the growing conviction that the Federal Reserve will cut rates at its next meeting, after softer-than-expected US inflation data. The annual US consumer price inflation inflation rate was unchanged at 2.7% in July. This was the same as in June but lower than the FXStreet-cited market consensus of an uptick to 2.8%....

13 August 2025, 08:05

European stocks mixed as US-China trade truce extended

London stocks rounded off the day mixed on Tuesday, as investors weighed news of a US-China tariff truce extension and steady US inflation numbers. The FTSE 100 index closed up 18.10 points, 0.2%, at 9,147.81. The FTSE 250 ended 46.80 points lower, 0.2%, at 21,842.69, while the AIM All-Share finished up 1.06 points, 0.1%, at 759.27. The Cboe UK 100 ended up 0.3% at 915.84,...

12 August 2025, 16:02

FTSE 100 in ‘measured’ gain before US data

Stocks in Europe were mostly higher on Tuesday midday ahead of US consumer price index data, as investors breathed a sigh of relief after a trade truce extension between the US and China. As part of their May truce, fresh US tariffs targeting China were reduced to 30% and the corresponding level from China was cut to 10%. Those rates will now hold until November ? or...

12 August 2025, 11:18

Better to travel as Entain shares fall despite raised outlook

Better than expected H1 Full-year outlook increased Shares up with events Global sports betting and gaming group Entain (ENT) reported double-digit increases in both net gaming revenue and profit for the first half of 2025, comfortably beating consensus estimates, and raised its full-year guidance. However, shares in the Ladbrokes and Coral brands owner have had a strong...

12 August 2025, 10:49

No respite for ailing staffing sector as PageGroup posts lower profits

Net fee income down 12% Weakness in France and Germany Full-year profit target confirmed Shares in PageGroup (PAGE) fell over 3% to 258p in morning trading as the recruiter reported a disappointing set of results for the six months ending 30 June. The company reported a 12.3% fall in half-year net fee income to £389.7 million compared with £444.1 million last year due to...

12 August 2025, 09:38

Bellway brightens sentiment with positive half-year update

Double-digit increase in volumes Prices also higher than last year Firm 'well positioned for growth' For the second time this year, Bellway (BWY) has ridden to the rescue to alleviate some of the gloomy sentiment around the housebuilding sector with positive news on sales and reservations. The shares, which were trading just shy of £30 in July but have been languishing...

12 August 2025, 09:07

Early market roundup: Stocks higher as US and China extend trade truce

Stock prices in Europe were mostly higher on Tuesday morning amid an extension of the US-China trade truce, while investors await US consumer price index inflation data and digest a UK unemployment reading. The FTSE 100 index traded up 21.34 points, 0.2%, at 9,151.05. The FTSE 250 added 51.59 points, 0.2%, at 21,941.08, and the AIM All-Share was up 2.44 points, 0.3%, at...

12 August 2025, 08:12

Late market roundup: FTSE 100 outperforms ahead of busy week for data

London stocks ended mostly lower on Monday, although the FTSE 100 surpassed its European peers ahead of UK jobs data and US inflation. Also, markets currently appear 'very relaxed' ahead of the deadline for US-China trade talks. The FTSE 100 index closed up 33.98 points, 0.4%, at 9,129.71. The FTSE 250 ended 69.06 points lower, 0.3%, at 21,889.49, while the AIM All-Share...

11 August 2025, 17:02

Lunchtime market roundup: FTSE 100 rises as US-China deadline looms

The FTSE 100 outperformed its European peers on Monday, trading higher around midday in London, weighing developments in Ukraine and prospects ahead of Tuesday's US-China trade talks deadline. The FTSE 100 index traded up 16.75 points, 0.2%, at 9,112.48. The FTSE 250 fell 80.96 points, 0.4%, at 21,877.59, and the AIM All-Share was down 2.77 points, 0.4%, at 759.69. The Cboe...

11 August 2025, 11:18

Hikma Pharmaceuticals and Vistry directors buy while GlobalData CFO sells | Directors Deals

Hikma chair spends £3.5 million Vistry chair backs builder GlobalData CFO raises cash Mazen Darwazah, executive chairman of drug manufacturer Hikma Pharmaceuticals (HIK), bought 200,000 shares at £17.56 for a total value of £3.5 million on 7 August. Darwazah's purchase comes after the company's core first-half operating profit fell by 7% to $373 million 'reflecting...

11 August 2025, 12:09

GSK shares up on US priority review for Gepotidacin

FDA accepts application for gepotidacin Positive phase-three trials GAK to receive $370m settlement Pharmaceutical firm GSK (GSK) said the US FDA (Food and Drug Administration) has accepted an application to review gepotidacin, its oral antibiotic to treat sexually transmitted uncomplicated gonorrhoea in patients 12 years and older. The shares ticked up 14p or 1% to...

11 August 2025, 10:55

1 2 3 4 5 6

Next >

Showing 1 to 16 of 16,671

Shares News

Late market roundup: FTSE 100 nears highs as US rate cut bets rise

Shares up and pound nears $1.36 on Fed rate-cut hope

Evoke shares gain after strong first half

Hill & Smith shares gain on share buyback and half-year profit rise

Beazley shares hit three-month low on outlook cut

Shares up as Fed cut bets build after US inflation data

European stocks mixed as US-China trade truce extended

FTSE 100 in ‘measured’ gain before US data

Better to travel as Entain shares fall despite raised outlook

No respite for ailing staffing sector as PageGroup posts lower profits

Bellway brightens sentiment with positive half-year update

Early market roundup: Stocks higher as US and China extend trade truce

Late market roundup: FTSE 100 outperforms ahead of busy week for data

Lunchtime market roundup: FTSE 100 rises as US-China deadline looms

Hikma Pharmaceuticals and Vistry directors buy while GlobalData CFO sells | Directors Deals

GSK shares up on US priority review for Gepotidacin

Most Read

Market Overview

UK 350 Risers and Fallers

Shares News

Most Read

Receive our daily news email

Subscribe to the latest investing news by entering your email address below

For five days a week you will get

Plus more useful investment content and occasional promotional offers.

Market Overview

UK 350 Risers and Fallers

Receive our
daily news email